Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Clinical Pharmacokinetics|January 1, 1997
Effect of renal impairment on the pharmacokinetics of grepafloxacinC Efthymiopoulos, S L Bramer, A Maroli, et al.Clinical Pharmacokinetics|March 7, 2000
Effect of multiple cilostazol doses on single dose lovastatin pharmacokinetics in healthy volunteersS L Bramer, J Brisson, A E Corey, et al.Journal of Clinical Pharmacology|December 1, 1999
Effect of disulfiram-mediated CYP2E1 inhibition on the disposition of vesnarinoneR F Frye, B Tammara, T D Cowart, et al.Journal of Pharmaceutical and Biomedical Analysis|August 23, 2001
Method for the quantitative analysis of cilostazol and its metabolites in human plasma using LC/MS/MSS L Bramer, P N Tata, S S Vengurlekar, et al.Journal of Pharmaceutical and Biomedical Analysis|January 30, 1999
LC/MS/MS analysis of vesnarinone and its principal metabolites in plasma and urineP N Tata, K S Schorno, T D Cowart, et al.Journal of Clinical Pharmacology|May 29, 1998
Effect of increasing gastric pH with famotidine on the absorption and oral pharmacokinetics of the inotropic agent vesnarinoneB Koneru, D T Cowart, M Noorisa, et al.Journal of Chromatography. B, Biomedical Sciences and Applications|July 16, 1999
Simultaneous quantitative determination of cilostazol and its metabolites in human plasma by high-performance liquid chromatographyC J Fu, P N Tata, K Okada, et al.Journal of Pharmaceutical and Biomedical Analysis|March 30, 1999
The quantitative determination of cilostazol and its four metabolites in human liver microsomal incubation mixtures by high-performance liquid chromatographyP N Tata, C H Fu, N J Browder, et al.Clinical Pharmacokinetics|January 1, 1997
Grepafloxacin pharmacokinetics in individuals with hepatic dysfunctionC Efthymiopoulos, S L Bramer, A Maroli, et al.Human & Experimental Toxicology|July 13, 2000
In vitro metabolism and interaction of cilostazol with human hepatic cytochrome P450 isoformsR Abbas, C P Chow, N J Browder, et al.Pageof 3